MBOT News and Press, Microbot Medical Inc. From 10/13/22

HINGHAM, Mass., Oct. 13, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) announced a significant development milestone as it completed the GLP animal study for the LIBERTY® Robotic System, the first disposable robotic system being developed for endovascular procedures. Th...

Microbot Medical ( NASDAQ: MBOT ) on Tuesday said it had decided to suspend research and development of its self-cleaning shunt (SCS) project, effective immediately. Shares of the micro-cap medical device company fell 4.6% to $4.79 in morning trading. The SCS w...

HINGHAM, Mass., Oct. 11, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) has announced that, following the recent acquisition of the endovascular assets of Nitiloop Ltd. along with other significant developments regarding the LIBERTY® Robotic System, including the commenc...

Israeli Patent Office issues patent allowance for Microbot Medical's ( NASDAQ: MBOT ) LIBERTY Robotic System, covering it’s roll assembly mechanism. “Our global patent portfolio continues to expand and build continued protection of our intelle...

HINGHAM, Mass., Oct. 10, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT) is continuing to expand its global intellectual property portfolio for the LIBERTY ® Robotic System as a patent allowance was issued by the Israeli Patent Office, covering the LIBERTY Robotic Sys...

Microbot Medical ( NASDAQ: MBOT ) has acquired the assets of privately-held medical device firm Nitiloop. Financial terms of the deal were not disclosed. The deal will strengthen Microbot Medical's ( MBOT ) LIBERTY Robotic System portfolio. It covers the U.S. FDA-a...

Integration with the LIBERTY® Robotic System & One & Done™ Technology May Enable Future Acceleration of Robotic Adoption; Represents an Additional Growth Opportunity by Accessing the $500 Million Chronic Total Occlusion (CTO) Market 1 through the Expansion of Robot...

HINGHAM, Mass., Oct. 04, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to be committed to expanding its capabilities, today announced the newest appointment to its Scientific Advisory Board (SAB), David C. Madoff, M.D. Dr. Madoff, Professor of Radiology and ...

Miami-based Physician Specializes in Minimally Invasive Treatments for Peripheral Vascular Disease, Cancer, and Other Diseases HINGHAM, Mass., Sept. 19, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), continuing its recent success of strengthening its Scientific Adv...

HINGHAM, Mass., Sept. 15, 2022 (GLOBE NEWSWIRE) -- Microbot Medical Inc. (Nasdaq: MBOT), which continues to build a network of global leaders in the endovascular interventional space for the LIBERTY® Robotic System, today announced that Vincent Vidal, M.D., PhD, has joined its Scientif...